FDA Shift On BPA May Tighten Squeeze On Infant Formula Manufacturers
This article was originally published in The Tan Sheet
Executive Summary
FDA's shift in position regarding the safety of bisphenol A likely will expedite the trend toward BPA-free packaging among infant formula marketers, even though existing science does not demonstrate a proven threat to babies and children